Skip to main content
Premium Trial:

Request an Annual Quote

Theradiag to Commercialize PredictImmune IBD Test in French-Speaking Europe and Africa

NEW YORK – Immune prognostic tools developer PredictImmune announced Monday an exclusive partnership for diagnostic company Theradiag to promote, license, and distribute the PredictSure IBD test in French-speaking countries in Europe and Africa.

France-based Theradiag, which specializes in in vitro diagnostics and theranostics for autoimmune disease, will lead commercialization in France, Belgium, Luxembourg, Switzerland, and the Maghreb countries in northwest Africa.

Other terms of the deal were not disclosed.

The IBD test, which was commercialized in the United Kingdom and Ireland earlier this year, will be PredictImmune's first product launch in continental Europe. The company recently announced a similar partnership with KSL Biomedical for North American commercialization of the IBD test.

The blood-based biomarker test, which leverages quantitative PCR technology, is meant to provide a preview of future disease outcomes at the point of diagnosis, allowing for better treatment choices earlier in the disease, Cambridge, UK-based PredictImmune said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.